Please login to the form below

Not currently logged in
Email:
Password:

kidney transplant

This page shows the latest kidney transplant news and features for those working in and with pharma, biotech and healthcare.

Otsuka finally gets FDA OK for kidney disease drug

Otsuka finally gets FDA OK for kidney disease drug

Otsuka finally gets FDA OK for kidney disease drug. Approval at last for rare disease treatment. ... to progression of kidney disease (measured using creatinine levels) and symptoms such as kidney pain and hypertension.

Latest news

  • Alexion's Soliris gets US approval for myasthenia gravis Alexion's Soliris gets US approval for myasthenia gravis

    The revamp was announced after Soliris failed to hit the mark in a trial in kidney transplant complications and allegations of sales fraud, which was followed by the departures of CEO

  • Price matters Price matters

    But it also doesn’t. Let’s conduct a social healthcare experiment: ask a thousand people if they would be willing to undergo a kidney transplant at 1960s prices - somewhere in ... And now ask them if they would be willing to undergo a kidney

  • Assisting adherence Assisting adherence

    Helping transplant patients. A particularly interesting case for medication non-adherence exists among transplant patients. ... Thus for transplant patients, those on the waiting list, and the healthcare system overall, safeguarding adherence and

  • Turning healthcare on its head Turning healthcare on its head

    A central component of Smiles that can Save Lives is a case study that examines the experiences of Lucy, a type 1 diabetes patient who, following complications, required a simultaneous kidney ... and pancreas transplant. “

  • Chimerix hit as lead drug brincidofovir flunks trial Chimerix hit as lead drug brincidofovir flunks trial

    time being has halted enrolment of the drug in two other trials involving kidney transplant patients. ... Brincidofocvir's failure in the stem cell transplant cell trial could hand an opportunity for Astellas and Vical, which are developing a DNA-based

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics